{
    "root": "3140f140-758c-41a6-83e2-8cb9be901863",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Betamethasone Dipropionate",
    "value": "20250314",
    "ingredients": [
        {
            "name": "BETAMETHASONE DIPROPIONATE",
            "code": "826Y60901U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31276"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "PROPYLENE GLYCOL MONOSTEARATE",
            "code": "MZM1I680W0",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "WHITE WAX",
            "code": "7G1J5DA97F",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_73702"
        },
        {
            "name": "PETROLATUM",
            "code": "4T6H12BN9U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11058"
        }
    ],
    "indications": {
        "text": "betamethasone dipropionate ointment ( augmented ) , 0.05 % corticosteroid indicated relief inflammatory pruritic manifestations corticosteroid-responsive dermatoses patients 13 years age older .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "apply thin film betamethasone dipropionate ointment ( augmented ) , 0.05 % affected skin areas twice daily . therapy discontinued control achieved . improvement seen within 2 weeks , reassessment diagnosis may necessary . betamethasone dipropionate ointment ( augmented ) , 0.05 % super-high-potency topical corticosteroid . treatment betamethasone dipropionate ointment ( augmented ) , 0.05 % exceed 50 g per week potential suppress hypothalamic-pituitary-adrenal ( hpa ) axis [ ( 5.1 ) ] . betamethasone dipropionate ointment ( augmented ) , 0.05 % used occlusive dressings unless directed physician . avoid face , groin , axillae , skin atrophy present treatment site . avoid contact eyes . wash hands application . betamethasone dipropionate ointment ( augmented ) , 0.05 % topical . oral , ophthalmic , intravaginal .",
        "doid_entities": [
            {
                "text": "face (DOID:0111084)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0111084"
            },
            {
                "text": "skin atrophy (DOID:2733)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2733"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "product : 50090-7517 ndc : 50090-7517-0 50 g tube",
    "adverseReactions": "betamethasone dipropionate ointment ( augmented ) , 0.05 % contraindicated patients hypersensitive betamethasone dipropionate , corticosteroids , ingredient preparation .",
    "indications_original": "Betamethasone dipropionate ointment (augmented), 0.05% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older.",
    "contraindications_original": "Apply a thin film of betamethasone dipropionate ointment (augmented), 0.05% to the affected skin areas once or twice daily.\n                  Therapy should be discontinued when control is achieved.  If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Betamethasone dipropionate ointment (augmented), 0.05% is a super-high-potency topical corticosteroid. Treatment with betamethasone dipropionate ointment (augmented), 0.05% should not exceed 50 g per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis [see Warnings and Precautions (5.1)].\n                  Betamethasone dipropionate ointment (augmented), 0.05% should not be used with occlusive dressings unless directed by a physician.\n                  Avoid use on the face, groin, or axillae, or if skin atrophy is present at the treatment site. \n                  Avoid contact with eyes. Wash hands after each application. \n                  Betamethasone dipropionate ointment (augmented), 0.05% is for topical use only. It is not for oral, ophthalmic, or intravaginal use.",
    "warningsAndPrecautions_original": "Product:    50090-7517\n                  NDC:    50090-7517-0   50 g in a TUBE",
    "adverseReactions_original": "Betamethasone dipropionate ointment (augmented), 0.05% is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation.",
    "drug": [
        {
            "name": "Betamethasone Dipropionate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31276"
        }
    ]
}